MS Society launch petition for NICE to reconsider Multiple Sclerosis decision
The MS Society has begun a petition calling for NICE, NHS England and drug manufacturer, Roche, to rethink NICE’s decision to reject the first treatment to be licensed for the treatment of primary progressive multiple sclerosis (PPMS). NICE announced in September that it would not be making ocrelizumab for PPMS available on the NHS in